取得演示
Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Miraca Life Sciences

7月 2026

7月 2026Miraca Life Sciences的市場佔有率分析

成立年份2012
僱員1001 - 5000
年度營收--
miracalifesciences.com
Miraca Life Sciences
Miraca Life Sciences(包含公司地區)
  • miracalifesciences.com
    miracalifesciences.com
查看更多網站流量與參與度資訊

Miraca Life Sciences的熱門網域總造訪量

了解Miraca Life Sciences市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

無可顯示數據

無可顯示數據

Miraca Life Sciences的熱門網域平均造訪時長

分析Miraca Life Sciences參與度指標。

過去 3 個月平均造訪時長

無可顯示數據

無可顯示數據

Miraca Life Sciences的熱門網域平均頁面瀏覽量

了解Miraca Life Sciences如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

無可顯示數據

無可顯示數據

想要取得更深入的流量洞見?

篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。



使用的熱門技術Miraca Life Sciences

这些是Miraca Life Sciences顶级域名使用的行业网站技术

音訊視訊媒體 (2)

行動裝置 (2)

Apple Mobile Tags

Apple Mobile Tags

預約 (1)

Cvent

Cvent

轉換與分析 (1)

Google Analytics

Google Analytics

更多技術

3

檢視所有

準備好開發優質潛在客戶了嗎?

借助 SimilarWeb 銷售情報解決方案,了解網站能使用哪些技術來完善銷售宣傳手法,並縮短銷售週期。


新聞與訊號來自Miraca Life Sciences

透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。

新聞Miraca Life Sciences acquired Plusdx on Nov 20th '25.Miraca Life Sciences ("MLS"), the leading provider of expert anatomic pathology services, today announced that it has acquired PLUS Diagnostics ("PLUS") from Water Street... * Johnson Controls Launches Enhanced Integrated Laboratory Services To Optimize R&D Facility Operations And Drive Scientific Productivity
新聞Water Street Healthcare Partners Llc sold assets to Miraca Life Sciences on May 1st '19.Miraca Life Sciences (“MLS”), the leading provider of expert anatomic pathology services, today announced that it has acquired PLUS Diagnostics (“PLUS”) from Water Street Healthcare Partners, a strategic investor focused exclusively on the healthcare industry.
新聞Biocept, Inc. partners with Miraca Life Sciences.Biocept, Inc. (NASDAQ: BIOC ), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that it has entered into a Promotion and Marketing Agreement with Miraca Life Sciences, Inc. (MLS) to market Biocept's Target Selector™ liquid biopsy tests and services to community-based oncologists and hematologists in specified sales territories in the United States.

查看所有Miraca Life Sciences信號

讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。